Jame Abraham

7PUBLICATIONS
55CO-AUTHORS
Molecular targetsTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPsychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 08, 2025
Human Epidermal Growth Factor Receptor 2 Positivity a Moving Target in the Era of Antibody-Drug Conjugates.

Marko Velimirovic, Jame Abraham

|Dec 20, 2024
Awareness, Knowledge, and Treatment Patterns of Nonmetastatic Inflammatory Breast Cancer in Low- and Middle-Income Countries: The BRIDGES Study.

Ilana Schlam, Kelly A Hirko, Daniela Shveid

|Aug 21, 2024
Current and Novel Treatment Options in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer.

Nerea Lopetegui-Lia, Revati Varma, Jame Abraham

|Oct 26, 2023
Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer.

Avia D Wilkerson, Prerana Bangalore Parthasarathy, Nickolas Stabellini

|Jun 21, 2022
Novel Radiomic Measurements of Tumor-Associated Vasculature Morphology on Clinical Imaging as a Biomarker of Treatment Response in Multiple Cancers.

Nathaniel Braman, Prateek Prasanna, Kaustav Bera

|Feb 02, 2021
Reflection on Supportive Care Elements During the Metastatic Breast Cancer Journey.

Erin Roesch, Jame Abraham

Pageof 2

Frequent Collaborators

2 joint publications

Alberto J Montero

2 joint publications

Erin Roesch

2 joint publications

Pingfu Fu

1 joint publications

Siddharth Kunte